Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccine in Cancer Patients on ICI
NCT03590808Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of influenza vaccine in influenza (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Seroprotection rate. Started Sep 2018; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03590808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03590808.